BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19829090)

  • 1. Clopidogrel resistance.
    Sugunaraj JP; Palaniswamy C; Selvaraj DR; Chaitanya Arudra SK; Sukhija R
    Am J Ther; 2010; 17(2):210-5. PubMed ID: 19829090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
    Siller-Matula J; Schrör K; Wojta J; Huber K
    Thromb Haemost; 2007 Mar; 97(3):385-93. PubMed ID: 17334505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in clopidogrel pharmacology and their relation to clinical outcomes.
    Gurbel PA; Antonino MJ; Tantry US
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):989-1004. PubMed ID: 19575629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent acute stent thrombosis due to allergic reaction secondary to clopidogrel therapy.
    Karabay CY; Can MM; Tanboğa IH; Ahmet G; Bitigen A; Serebruany V
    Am J Ther; 2011 Jul; 18(4):e119-22. PubMed ID: 20683245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents and antiplatelet resistance.
    Simon DI; Jozic J
    Am J Cardiol; 2008 Nov; 102(9 Suppl):29J-37J. PubMed ID: 18928790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of clopidogrel in the management of ischemic heart disease.
    Galla JM; Lincoff AM
    Curr Opin Cardiol; 2007 Jul; 22(4):273-9. PubMed ID: 17556877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis.
    Milicic D; Skoric B; Lovric D
    J Invasive Cardiol; 2009 Aug; 21(8):E157-60. PubMed ID: 19652267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clopidogrel responsiveness after drug-eluting stent implantation.
    Price MJ
    Minerva Cardioangiol; 2009 Oct; 57(5):657-66. PubMed ID: 19838155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
    Angiolillo DJ; Suryadevara S; Capranzano P; Zenni MZ; Guzman LA; Bass TA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):1-14. PubMed ID: 19089929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing.
    Azam SM; Jozic J
    Transl Res; 2009 Dec; 154(6):309-13. PubMed ID: 19931197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
    Pinto Slottow TL; Bonello L; Gavini R; Beauzile P; Sushinsky SJ; Scheinowitz M; Kaneshige K; Xue Z; Torguson R; Tantry U; Pichard AD; Satler LF; Suddath WO; Kent K; Gurbel P; Waksman R
    Am J Cardiol; 2009 Aug; 104(4):525-30. PubMed ID: 19660606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel resistance?
    Gurbel PA; Tantry US
    Thromb Res; 2007; 120(3):311-21. PubMed ID: 17109936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent thrombosis in a clopidogrel nonresponder.
    Laird PA; Ruppert SD
    Crit Care Nurs Q; 2012; 35(2):151-9. PubMed ID: 22407371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.
    Vila PM; Zafar MU; Badimon JJ
    Platelets; 2009 Dec; 20(8):531-8. PubMed ID: 19845440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Alfonso F; Macaya C; Bass TA; Costa MA
    J Am Coll Cardiol; 2007 Apr; 49(14):1505-16. PubMed ID: 17418288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.